Fully cell-free process aims to democratize personalized cancer therapeutics with shorter turnaround and negligible bioburden ...

Study reveals how cells regulate repair protein production to prevent DNA damage over-repair or under-repair, aiding cell ...

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the ...

In order to produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic ...

Every living cell must interpret its genetic code - a sequence of chemical letters that governs countless cellular functions.

Nerve cells are not just nerve cells. Depending on how finely we distinguish, there are several hundred to several thousand ...

Adding stereotactic ablative radiotherapy (SAbR) to neoadjuvant chemotherapy improves pathologic outcomes for patients ...

The Stowers Institute for Medical Research in Kansas City is one of the primary beneficiaries of The American Century ...

NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announced plans to change the ratio of its American Depository Shares (“ADSs”) to its ordinary shares from one (1) ADS, representing twenty-five ...

NuCana plc (NASDAQ: NCNA) ("NuCana" or the "Company") announced plans to change the ratio of its American Depository Shares ("ADSs") to its ...

Takara Bio Europe has signed a strategic distribution agreement with MACHEREY-NAGEL, opening up new commercial opportunities ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...